A kind of cik cell cryopreservation liquid and cryopreservation method

A cryopreservation method and cryopreservation solution technology, which is applied to the preservation and application of animal cells, human or animal bodies, etc., can solve the problems of complex cryopreservation procedures, reduced activity, and difficulty in obtaining serum autologous serum, etc., and achieve simplified cryopreservation. storage method, the effect of improving the survival rate

Active Publication Date: 2017-12-22
ADLAI NORTYE BIOPHARMA CO LTD
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, the serum-free cryopreservation solution reduces the activity of frozen cells after recovery, which cannot achieve our goal of efficient value-added.
However, the use of serum is difficult to obtain autologous serum, and exogenous serum has the risk of infectious diseases
Moreover, the existing cryopreservation procedures are complicated, which is not conducive to the actual operation.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of cik cell cryopreservation liquid and cryopreservation method
  • A kind of cik cell cryopreservation liquid and cryopreservation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] Example 1: Preparation of logarithmic phase CIK cells

[0067] (1) Separate peripheral blood mononuclear cells from peripheral blood, resuspend in X-VIVO15 serum-free medium, and make the cell concentration of peripheral blood mononuclear cells 1×10 6 cells / mL, add IL-2 at the same time, so that the concentration of IL-2 is 1×10 3 U / mL, static culture for 3 days;

[0068] (2) Add X-VIVO15 serum-free medium to 100 mL in the culture medium prepared in step (1), and add IL-2 at the same time, so that the concentration of IL-2 is 1×10 3 U / mL, static culture for 1 day;

[0069] (3) Add X-VIVO15 serum-free medium to 200-240mL to the culture medium prepared in step (2), and add IL-2 at the same time, so that the concentration of IL-2 is 1×10 3 U / mL, static culture for 3 days; seed CIK cells in the logarithmic growth phase were prepared.

Embodiment 2

[0070] Embodiment 2: the preparation of CIK cell cryopreservation liquid

[0071] (1) Place human autologous plasma in a sterile centrifuge tube and centrifuge at 1800rpm for 6 minutes;

[0072] (2) Absorb the upper layer of plasma, transfer it to a new centrifuge tube, centrifuge at 3000rpm for 20 minutes, and absorb the supernatant, which is the human autologous plasma for cryopreservation;

[0073] (3) Mix dimethyl sulfoxide, the above-mentioned human autologous plasma, and medium X-VIVO15 at a volume ratio of 1:4:5 to obtain CIK cell cryopreservation solution.

Embodiment 3

[0074] Example 3: Cryopreservation of CIK cells

[0075] (1) Take the CIK cells cultured to the 7th day, centrifuge at 1800rpm for 6 minutes, discard the supernatant, add the above CIK cell freezing solution, and adjust the cell concentration to 1*10 8 Each / mL, each / 5mL was added to a 5mL sterile cryopreservation tube. Place the cryovials in a programmed cooling box pre-cooled at 4°C;

[0076] (2) Place the programmed cooling box with the cryopreservation tube in a -80°C refrigerator for 24 hours, and then store the cryopreservation tube in liquid nitrogen for long-term storage.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a cryopreservation solution and a cryopreservation method for CIK cells. The invention uses human autologous plasma instead of serum to avoid the risk of infectious diseases in exogenous serum, and the reagents used are suitable for the simple programmed cooling method of the programmed cooling box. The reagent of the present invention contains dimethyl sulfoxide, autologous plasma and culture medium at a ratio of 1:4:5. The invention has the characteristics of simple method and high cell recovery activity. It is suitable for patients who are undergoing radiotherapy and chemotherapy or healthy people to store immune cells in the form of CIK cells for future CIK cell therapy.

Description

technical field [0001] The invention belongs to the technical field of cell cryopreservation, and in particular relates to a novel CIK cell cryopreservation solution and a cryopreservation method. The invention avoids the risk of infectious diseases caused by exogenous serum by adding human autologous plasma, and the reagents used are suitable for the simple programmed cooling method of the programmed cooling box. The invention has the characteristics of simple method and high cell recovery activity. Background technique [0002] CIK cells, Cytokine-Induced Killer (CIK) cells are a new type of immunocompetent cells. CIK cells have strong proliferation ability, strong cytotoxicity, and certain immune characteristics. Because the cells express two membrane protein molecules, CD3 and CD56, they are also called NK cell (natural killer cell)-like T lymphocytes, which have both the strong anti-tumor activity of T lymphocytes and the non-MHC restriction of NK cells. Tumor killing...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/07A01N1/02
Inventor 何学松闫桂云杨东晖路杨
Owner ADLAI NORTYE BIOPHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap